What you haven't received, which you will—we'll make sure it gets to your offices—is the remaining business items from the previous session of the House of Commons.
There's Bill C-36, an act respecting the safety of consumer products. This bill has received first reading but has not been referred to the committee. The committee could potentially deal with legislation in the fall.
Regarding the study on the cancellation of the HIV vaccine manufacturing facility under the Canadian HIV vaccine initiative, a draft report has been considered by the committee, and all of the text and recommendations were adopted with amendments; however, the committee wanted to review a second draft with the changes before officially adopting the report. Possible time required would be an hour or an hour and a half meeting on this.
A letter on rare disorders was distributed to committee members but has not been discussed by the committee.
Concerning a study on the impact of microwaves on human health, we tried very hard to get that topic on the agenda. The committee has not yet decided whether they're going to report on this issue. Witnesses have been lobbying for a report. We haven't gone to that stage yet.
And the committee passed a motion in June to undertake a review of the Assisted Human Reproduction Agency of Canada.
So we have all these issues, which I would like you to come prepared for next Tuesday. We're going to put this all down on our order of business.
Are there any comments or questions?
Monsieur Malo.